GeneReach Biotechnology Corp. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was TWD 186.222 million compared to TWD 80.548 million a year ago. Operating income was TWD 82.873 million compared to TWD 22.596 million a year ago. Net income was TWD 68.305 million compared to TWD 18.165 million a year ago. Basic earnings per share was TWD 1.68 compared to TWD 0.45 a year ago. For the nine months, sales was TWD 574.055 million compared to TWD 244.061 million a year ago. Operating income was TWD 232.241 million compared to TWD 72.261 million a year ago. Net income was TWD 166.302 million compared to TWD 62.100 million a year ago. Basic earnings per share was TWD 4.1 compared to TWD 1.64 a year ago. Diluted earnings per share was TWD 4.1 compared to TWD 1.57 a year ago.